novo nordisk cuts prices for its glp-1 drugs. Wegovy price by up to 37% in India Novo Nordisk to cut 9,000

However, these medications are not suitable for everyone

Metabolism 96:4655 Gilbert MP, Pratley RE (2020) GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials

Aging brings many changes, especially when it comes to metabolism and weight management

Its important to remember that GLP-1 medications are not instant solutions

95 In contrast, another study found that resistin levels were higher in T2D patients and individuals with impaired fasting glucose

Additionally, because many people with diabetes or who are overweight may control their condition with diet, other medications and therapies, or choose to not seek treatment, not all people who meet these clinical criteria would use GLP-1 drugs